It's somewhat irrelevant that we get quick approval. The real question is, "What will the U.S. market for our vaccine look like in November?"
Also, is China waiting for our GMP? Are we going to need more money/funding (dilution?) to get us to November? ... or will NGIO listing take care of funding?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links